Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies

Background: Immune checkpoint inhibitors (ICIs) are now an important option for more than 14 different cancers. Recent series case reports have described that ICIs are associated with new-onset diabetes in patients, yet the definitive risk is not available. We thus performed a meta-analysis of rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jingli, Yang, Jing, Liang, Yan, Meng, Haiyang, Zhao, Junjie, Zhang, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915045/
https://www.ncbi.nlm.nih.gov/pubmed/31920646
http://dx.doi.org/10.3389/fphar.2019.01453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915045/
https://www.ncbi.nlm.nih.gov/pubmed/31920646
http://dx.doi.org/10.3389/fphar.2019.01453

Ejemplares similares